Search Login Register

Chronic Pancreatitis Summary

Description: INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.

Also Known As: Pancreatitis, Chronic

Networked: 4025 relevant articles (173 outcomes, 426 trials/studies) for this Disease

Key Drugs and Agents for Chronic Pancreatitis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Secretin : 7 outcomes 18 studies in 205 results : FDA 2
  2. Glucose (Dextrose) : 7 outcomes 6 studies in 103 results : FDA 175 Generic
  3. Enzymes : 6 outcomes 11 studies in 107 results : IBA
  4. Trypsin : 6 outcomes 6 studies in 132 results : IBA
  5. Amylases : 5 outcomes 7 studies in 111 results : FDA 1
  6. Antioxidants : 5 outcomes 7 studies in 30 results : IBA
  7. Pancreatic Elastase (Elastase) : 4 outcomes 5 studies in 53 results : IBA
  8. Pancrelipase (Creon) : 4 outcomes 5 studies in 17 results : FDA 1
  9. Insulin (Novolin) : 3 outcomes 10 studies in 168 results : FDA 2
  10. Lipase (Acid Lipase) : 3 outcomes 5 studies in 77 results : FDA 1
Show All >>

Diseases Related to Chronic Pancreatitis

  1. Pain (Aches)
  2. Pancreatitis
  3. Pancreatic Neoplasms (Pancreatic Cancer)
  4. Fibrosis (Cirrhosis)
  5. Pathologic Constriction (Stenosis)
Show All >>

Key Therapies for Chronic Pancreatitis

Efficacy Chart >>
  1. Pancreatectomy : 14 outcomes 18 studies in 318 results
  2. Stents : 13 outcomes 9 studies in 117 results
  3. Pancreaticoduodenectomy : 7 outcomes 16 studies in 169 results
  4. Pancreaticojejunostomy : 7 outcomes 8 studies in 112 results
  5. Lithotripsy (Extracorporeal Shockwave Lithotripsy) : 4 outcomes 2 studies in 41 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.